1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Olverembatinib: new trials by email Literature Review of Olverembatinib trials Research Report on Olverembatinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. olverembatinib - Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase | Phase 3 | Unknown | Shenzhen Second People's Hospital | 40 | 2022-07-01 | 2022-07-29 |
Leukemia, Myeloid, Chronic-Phase (1)
Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Myeloproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
olverembatinib (1)
Shenzhen Second People's Hospital (1)
China (1)
Xin Du, Phd (1)